ClinVar Miner

Submissions for variant NC_000017.10:g.(?_41249295)_(41320078_?)dup

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV004581265 SCV005065359 uncertain significance Hereditary breast ovarian cancer syndrome 2017-12-12 criteria provided, single submitter clinical testing This variant has not been reported in the literature in individuals with BRCA1-related disease. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the duplicated amino acids is currently unknown. This variant is a gross duplication of the genomic region encompassing the non-coding exon 1, the coding exons 2-7, and the first 12 nucleotides of exon 8 of the BRCA1 gene (c.-42819_559dup). The duplicated copy of this region is in tandem and while it preserves the integrity of the BRCA1 reading frame, the effect of this variant on BRCA1 expression is unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.